Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

SELL
$32.09 - $37.51 $731,780 - $855,378
-22,804 Reduced 95.4%
1,099 $36,000
Q2 2023

Aug 11, 2023

SELL
$36.12 - $41.79 $88,277 - $102,134
-2,444 Reduced 9.28%
23,903 $876,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $73,422 - $95,585
-1,864 Reduced 6.61%
26,347 $1.07 Million
Q3 2022

Nov 10, 2022

BUY
$43.76 - $53.42 $273,806 - $334,248
6,257 Added 28.5%
28,211 $1.24 Million
Q2 2022

Aug 15, 2022

BUY
$46.53 - $55.17 $434,450 - $515,122
9,337 Added 74.0%
21,954 $1.15 Million
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $421,357 - $522,114
9,210 Added 270.33%
12,617 $653,000
Q4 2021

Feb 10, 2022

BUY
$41.32 - $61.25 $140,777 - $208,678
3,407 New
3,407 $201,000
Q2 2020

Aug 13, 2020

SELL
$30.12 - $36.54 $253,309 - $307,301
-8,410 Closed
0 $0
Q1 2020

May 15, 2020

SELL
$27.03 - $38.62 $416,802 - $595,520
-15,420 Reduced 64.71%
8,410 $275,000
Q4 2019

Feb 13, 2020

BUY
$32.92 - $37.36 $784,483 - $890,288
23,830 New
23,830 $934,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track L2 Asset Management, LLC Portfolio

Follow L2 Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of L2 Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on L2 Asset Management, LLC with notifications on news.